Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia

被引:36
作者
Choi, P. [1 ]
Kavasery, R. [2 ]
Desai, M. M. [1 ]
Govindasamy, S. [3 ]
Kamarulzaman, A. [3 ]
Altice, F. L. [2 ,3 ]
机构
[1] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Chron Dis Epidemiol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Med, Sect Infect Dis,AIDS Program, New Haven, CT 06520 USA
[3] Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia
关键词
Malaysia; prisoners; HIV; AIDS; substance abuse; re-entry; HIV stigma; SUBSTITUTION TREATMENT; SUBSTANCE USE; HEALTH-CARE; ANTIRETROVIRAL THERAPY; DEPENDENT PATIENTS; PUBLIC-HEALTH; DRUG-USERS; RELEASE; STIGMA; MEN;
D O I
10.1258/ijsa.2009.009180
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-infected prisoners face an inordinate number of community re-entry challenges. In 2007, 102 HIV-infected prisoners in Malaysia were surveyed anonymously within six months prior to release to assess the prevalence and correlates of community re-entry challenges. Staying out of prison (60.8%), remaining off drugs (39.2%), finding employment (35.3%) and obtaining HIV care (32.4%) were the re-entry challenges reported most frequently. Global stigma, negative self-image and public attitudes-related stigma were independently associated with challenges to obtaining HIV care. In multivariate analyses, those with previous incarcerations (adjusted odds ratio [AOR], 3.2; 95% confidence interval [CI], 1.4-7.6), higher HIV-related symptoms (AOR, 2.0; 95% CI, 1.0-4.1) and higher public attitudes-related stigma (AOR, 2.5; 95% CI, 1.2-5.1) had a significantly higher likelihood of identifying more re-entry challenges. Targeted interventions, such as effective drug treatment, HIV care and public awareness campaigns, are crucial for stemming the HIV epidemic and improving health outcomes among HIV-infected prisoners in Malaysia.
引用
收藏
页码:416 / 423
页数:8
相关论文
共 60 条
[21]  
Jarrett NC, 2006, J HEALTH CARE POOR U, V17, P70, DOI 10.1353/hpu.2006.0046
[22]   Development and validation of a self-completed HIV symptom index [J].
Justice, AC ;
Holmes, W ;
Gifford, AL ;
Rabeneck, L ;
Zackin, R ;
Sinclair, G ;
Weissman, S ;
Neidig, J ;
Marcus, C ;
Chesney, M ;
Cohn, SE ;
Wu, AW .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 :S77-S90
[23]  
KAMARULZAMAN A, 2003, 15 ANN C AUSTR SOC H
[24]  
Keen J, 2000, BRIT J GEN PRACT, V50, P48
[25]   Expressed needs and behavioral risk factors of HIV-positive inmates [J].
Lanier, MM ;
Paoline, EA .
INTERNATIONAL JOURNAL OF OFFENDER THERAPY AND COMPARATIVE CRIMINOLOGY, 2005, 49 (05) :561-573
[26]   A Literature Review of International Implementation of Opioid Substitution Treatment in Prisons: Equivalence of Care? [J].
Larney, Sarah ;
Dolan, Kate .
EUROPEAN ADDICTION RESEARCH, 2009, 15 (02) :107-112
[27]  
LaVigne Nancy, 2004, VOICES EXPERIENCE FO
[28]   Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS [J].
Lawrinson, Peter ;
Ali, Robert ;
Buavirat, Aumphornpun ;
Chiamwongpaet, Sithisat ;
Dvoryak, Sergey ;
Habrat, Boguslaw ;
Jie, Shi ;
Mardiati, Ratna ;
Mokri, Azarakhsh ;
Moskalewicz, Jacek ;
Newcombe, David ;
Poznyak, Vladimir ;
Subata, Emilis ;
Uchtenhagen, Ambrose ;
Utami, Diah S. ;
Vial, Robyn ;
Zhao, Chengzheng .
ADDICTION, 2008, 103 (09) :1484-1492
[29]  
Lee R.S., 2002, AIDS and Behavior, V6, P309, DOI [DOI 10.1023/A:1021144511957, 10.1023/A:1021144511957]
[30]  
Leete R., 2004, KELANTANS HUMAN DEV